When makers of infant formula hear that babies got sick or died while using their products, what happens next is left largely ...

The Trump administration has cut investments in programs and agencies that prevent, track and respond to health hazards the federal government is now confronting.

The Hikma v. Amarin ruling brings clarity, but not new opportunities; White House adds pandemic response staff as Ebola cases ...

June lifts biotech funding rounds; BridgeBio nets a $1 billion raise; Why Anthropic is bringing AI to drug development.

Cocrystal Pharma named James Sapirstein as its CEO. Mary Lantin replaced founder Jeff Brandes as president and CEO of Azara ...

House China panel questions Bristol Myers, Pfizer on trial sites; Eli Lilly and Regeneron selected for the FDA’s new PreCheck ...

BioCryst announced it would close its Discovery Center of Excellence facility in Birmingham, Alabama, by the end of this year ...

MM+M editor-at-large Steve Madden shares encounters, conversations and updates from the International Festival of Creativity.

Launch prices for prescription drugs fell last year; Biogen culls Apellis pipeline following deal; Sanofi in EU crosshairs ...

The 7-2 decision blocks a Missouri failure-to-warn claim and leans heavily on medical-device precedent, giving healthcare ...

The U.S. added 24 awards on day four of the Cannes Lions International Festival of Creativity — four golds, eight silvers and ...

Roche launches a gene sequencing machine to challenge Illumina; The Supreme Court rejected a case involving New York’s past ...